EDGAR Filing Documents for 0000905718-16-001726

Form SC 13D - General statement of acquisition of beneficial ownership:

SEC Accession No. 0000905718-16-001726

Filing Date

2016-11-03

Accepted

2016-11-03 16:05:23

Documents

Group Members

ABINGWORTH BIOVENTURES VI, LP

Document Format Files

Seq	Description	Document	Type	Size
1	SC 13D	crispr13doct242016.htm	SC 13D	88861
	Complete submission text file	0000905718-16-001726.txt		90278

Mailing Address 38 JERMYN STREET LONDON X0 SW1Y 6DN

Business Address 38 JERMYN STREET LONDON X0 SW1Y 6DN 44 (0)20 7534 1500

Abingworth LLP (Filed by) CIK: 0001397144 (see all company filings)

IRS No.: 980518585 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: SC 13D

Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139

Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 6173154600

CRISPR Therapeutics AG (Subject) CIK: 0001674416 (see all company filings)

IRS No.: 473173478
Type: SC 13D | Act: 34 | File No.: 005-89674 | Film No.: 161971562
SIC: 2836 Biological Products, (No Diagnostic Substances)